10/8/2024CSPC Announces Regulatory Milestones in China and the U.S.

10/8/2024AstraZeneca Expanding R&D pipeline in China

10/8/2024Aadi Bio Wins Arbitration, Rejecting Multimillion-Dollar Claim from Ch...

10/8/2024CStone to Report Positive Preclinical Data of Anticancer Candidate CS2...

10/8/2024China Grants Conditional Approval to Biogen's ALS Therapy Qalsody

10/8/2024NRDL China: 2024 Outlook (Simon Kucher)

10/3/2024WuXi Considers Asset Sales Amid BIOSECURE Scrutiny: FT

10/3/2024Domestic Pharma Companies Saw Rapid Growth in Outlicensing Deals in 20...

10/3/2024Recent Executive Moves

10/2/2024China Introduces Credit System for Hospital and Pharmacy Staff to Curb...

10/2/2024China Issues New Regulation on Network Data Security Management

10/2/2024CDE Solicits Comments on the Proposed Technical Guidelines for Writing...

10/2/2024CDE Solicits Comments on the Proposed BE Study Guidelines for Five Gen...

10/2/2024CDE Solicits Comments on the Proposed Technical Guidelines for Clinica...

10/2/2024CDE Solicits Comments on the Proposed Technical Guidelines for Clinica...

10/2/2024Publication Announcement on the Inclusion of Marstacimab as Pilot Proj...

10/1/2024Asieris Pharma Reports Positive Phase III Results for Cervical HSIL Tr...

10/1/2024Kailera Secures $400M Series A Funding to Develop Obesity and Diabetes...

10/1/2024HUTCHMED Announces Japan Approval for FRUZAQLA (fruquintinib) Received...

10/1/2024NH Reports MAT H1/2024 Data on the Chinese Cough, Cold and Allergy Mar...

10/1/2024InventisBio Prevails in Trade Secret Misappropriation Lawsuit Filed by...

10/1/2024Alphamab and CSPC Enter a Licensing Deal on Anti-HER2 BsADC JSKN003 in...

10/1/2024Genentech to Acquire Regor Pharma’ Next-Generation CDK Inhibitor Port...

10/1/2024Akeso's Ebronucimab (PCSK9) Approved for Hypercholesterolemia in China

10/1/2024NMPA Conditionally Approves Qilu's QL1706 (Iparomlimab + Tuvonralimab)...

10/1/2024AstraZeneca's Seeks Chinese Approval of Antisense Therapy Eplontersen ...

10/1/2024Biotheus to Initiate Phase 3 Trial of BsAb PM8002 for SCLC

10/1/2024Regeneron and Sanofi Announced Chinese Approval of Dupixent as the Fir...

10/1/2024MediLink Registers Phase 3 Trial of Its B7H3 ADC YL201

10/1/2024Lepu Biopharma Files NDA for Lead Product EGFR ADC MRG003

Page:47/774 Total number of articles:23207: [First][<<] [45] [46] [47] [48] [49] [>>] [End]